Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An antiphospholipid syndrome that occurs as an isolated disorder.
Biomarker and diagnostic research for primary antiphospholipid syndrome has been reported in the published literature.
3 clinical trials registered, 2 recruiting. Interventions under study include drug therapy, other interventions, and biologic therapy. Pipeline includes 1 PHASE2, 1 NA. Research is primarily sponsored by academic and government institutions.
64 publications have been identified in PubMed for primary antiphospholipid syndrome. Research spans Case Report / Case Series (38%), Epidemiology / Natural History (23%), and Basic Science / Preclinical (13%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 24 |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 12:12 PM UTC
38%
Disease patterns and progression | 15 | 23% |
Laboratory research | 8 | 13% |
Research summaries | 7 | 11% |
Other research | 4 | 6% |
Testing and diagnosis research | 4 | 6% |
New treatment approaches | 2 | 3% |
Esparza Salazar F (2026). [PMID: 41717184](https://pubmed.ncbi.nlm.nih.gov/41717184/). *Cureus*. [Case Report / Case Series]
Gavris C (2026). [PMID: 41869346](https://pubmed.ncbi.nlm.nih.gov/41869346/). *Front Immunol*. [Review / Meta-Analysis]
Cabral AR (2026). [PMID: 40693427](https://pubmed.ncbi.nlm.nih.gov/40693427/). *Clin Exp Rheumatol*. [Case Report / Case Series]
Lopes AR (2026). [PMID: 41966085](https://pubmed.ncbi.nlm.nih.gov/41966085/). *ARP Rheumatol*. [Epidemiology / Natural History]
Naoum S (2026). [PMID: 41571489](https://pubmed.ncbi.nlm.nih.gov/41571489/). *Ann Rheum Dis*. [Review / Meta-Analysis]
Sciascia S (2026). [PMID: 41623307](https://pubmed.ncbi.nlm.nih.gov/41623307/). *Kidney Med*. [Gene Therapy / Novel Therapeutics]
Argyropoulou OD (2026). [PMID: 41930658](https://pubmed.ncbi.nlm.nih.gov/41930658/). *Clin Exp Rheumatol*. [Other]
Baltsiotis M (2026). [PMID: 41869321](https://pubmed.ncbi.nlm.nih.gov/41869321/). *Front Immunol*. [Basic Science / Preclinical]
van der Woude SFS (2026). [PMID: 41369605](https://pubmed.ncbi.nlm.nih.gov/41369605/). *JACC Case Rep*. [Case Report / Case Series]
Mameli A (2026). [PMID: 41529572](https://pubmed.ncbi.nlm.nih.gov/41529572/). *J Neurol Sci*. [Diagnostic / Biomarker]